Introduction
JIA is an umbrella term used to describe a heterogeneous group of diseases. To date no specific markers exist in clinical practice to predict disease activity & outcome. MRP 8/14 are calcium-binding proteins secreted by infiltrating phagocytes in synovial inflammation. Studies have shown that serum (Se) concentrations correlate sensitively & specifically with synovial inflammation in JIA. It is believed that they are predictive biomarkers that can identify subclinical disease activity, patients at risk of relapse during times of clinically inactive disease, and patients more likely to respond to Rx with MTX. Results 32 children (20 JIA, 12 DA) had Se samples taken for CRP, ESR & MRP 8/14 levels at diagnosis. 14 of these children had paired SF samples taken. Table 1 
Conclusion
MRI with contrast remains the gold standard for dx of synovitis. In reality, clinical assessment is the major diagnostic tool. DA is a more challenging condition than JIA, in light of confounding illness & the oftenassociated non-verbal state. In DA a simple biomarker of disease would be invaluable. We have shown that CRP is a poor marker of disease activity in JIA & DA, so the need for a more specific biomarker is evident. Our preliminary results suggest that children with DA have elevated SF levels of MRP 8/14 that correlate to disease activity. SF MRP 8/14 measurements are significantly higher than their paired Se samples, however our results show significant positive correlation between the two. This suggests that Se MRP 8/14 levels are potentially accurate markers of SF levels. MRP 8/14 may be a useful biomarker in DA, aiding timely dx & instigation of appropriate Rx, helping to improve clinical outcomes for this group. 
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